It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Although the normal physiological level of oxidative stress is beneficial for maintaining bone homeostasis, imbalance between reactive oxygen species (ROS) production and antioxidant defense can cause various bone diseases. The purpose of this study was to determine whether nicotinamide (NAM), an NAD+ precursor, can support the maintenance of bone homeostasis by regulating osteoblasts. Here, we found that NAM enhances osteoblast differentiation and mitochondrial metabolism. NAM increases the expression of antioxidant enzymes, which is due to increased FOXO3A transcriptional activity via SIRT3 activation. NAM has not only a preventive effect against weak and chronic oxidative stress but also a therapeutic effect against strong and acute exposure to H2O2 in osteoblast differentiation. Collectively, the results indicate that NAM increases mitochondrial biogenesis and antioxidant enzyme expression through activation of the SIRT3-FOXO3A axis, which consequently enhances osteoblast differentiation. These results suggest that NAM could be a potential preventive or therapeutic agent for bone diseases caused by ROS.
Bone health: Vitamin B3 boosts anti-oxidants
A form of vitamin B3 called nicotinamide (NAM) has potential to prevent or treat bone diseases related to oxidative stress by boosting production of anti-oxidant enzymes. Mitochondria, the powerhouses of the cell, produce reactive oxygen species (ROS) during normal metabolism. If these ROS are not countered by enough anti-oxidants, oxidative stress can decrease production of bone-building cells called osteoblasts, leading to bone aging and osteoporosis. Hyun-Mo Ryoo and Woo-Jin Kim at Seoul National University in South Korea and co-workers investigated whether NAM, the precursor of a key mitochondrial molecule, could restore ROS balance. In experiments in bone cells, NAM improved mitochondrial function, boosted anti-oxidant production, and promoted osteoblast formation. NAM prevented and repaired oxidative damage in bone cells and therefore shows potential both as a preventative and therapeutic treatment for bone health.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Seoul National University, Department of Molecular Genetics & Dental Pharmacology, School of Dentistry and Dental Research Institute, Dental Multi-omics Center, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
2 Seoul National University, Department of Molecular Genetics & Dental Pharmacology, School of Dentistry and Dental Research Institute, Dental Multi-omics Center, Seoul, South Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Seoul National University and Seoul National University Dental Hospital, Department of Periodontology, School of Dentistry and Dental Research Institute, Seoul, South Korea (GRID:grid.459982.b) (ISNI:0000 0004 0647 7483)